Table 10 |
||||
|
Relationship of dosing to time and success of intercourse for tadalafil 20 mg and placebo in four trials |
||||
|
Time after dose (hours) |
||||
|
|
||||
|
Outcome |
<0.5 to 4 |
>4 to 12 |
>12 to 24 |
>24 to 36 |
|
|
||||
|
Percent of total attempts at intercourse |
||||
|
Placebo |
75 |
15 |
9.0 |
1.7 |
|
Tadalafil 20 mg |
61 |
23 |
12 |
3.7 |
|
|
||||
|
Percent of successful attempts at intercourse |
||||
|
Placebo |
74 |
15 |
8.4 |
3.3 |
|
Tadalafil 20 mg |
60 |
23 |
13 |
4 |
|
|
||||
|
Percent of attempts that were successful |
||||
|
Placebo |
26 |
26 |
24 |
50 |
|
Tadalafil 20 mg |
65 |
68 |
72 |
74 |
|
|
||||
|
Moore et al. BMC Urology 2005 5:18 doi:10.1186/1471-2490-5-18 |
||||